This cross-reactivity means metabolic effects (including hypoglycemia at higher doses) are possible in research models and should be monitored in in vivo protocols
For more persistent pigmentation concerns, medical treatments may be required after evaluation by a doctor
The weight loss achieved by CagriSema (-20.4% at 68 weeks) is comparable to that reported with the dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonist tirzepatide (-20.9% with the 15-mg dose at 72 weeks in SURMOUNT-1) [14]
At a minimum, confirm the label shows a clearly stated country of manufacture, a local importers name and contact details, a batch or lot number, and manufacturing and expiry dates that match the date printed on the base of the container
FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m6A modifications of multiple pro-angiogenic factors
Knowledge regarding diagnosis and treatment of oral pigmented lesions can help dental professionals in timely and accurate management of these lesions